
Application note
Improving automated cell culture with full length Biolaminin®
Learn how Biolaminin 521 enables scalable, automation-ready cell therapy manufacturing. This application note shows how Biolaminin maintains cell quality and consistency while reducing variability and culture failures in automated workflows. Discover a reliable solution for high-quality, clinically compliant cell production.
What’s inside
- Compatibility of Biolaminin® 521 with automated cell culture platforms
- Data showing efficient iPSC expansion on the Ascent FBR system
- Results demonstrating enhanced cell growth in the QES hollow fiber bioreactor
- Validation of hPSC morphology and pluripotency after automated single-cell subcloning